INC Research Holdings Inc. (NASDAQ:INCR) Director Robert W. Breckon sold 12,197 shares of the business’s stock in a transaction dated Monday, September 26th. The shares were sold at an average price of $44.16, for a total value of $538,619.52. Following the completion of the transaction, the director now directly owns 15,561 shares of the company’s stock, valued at approximately $687,173.76. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website.
Shares of INC Research Holdings Inc. (NASDAQ:INCR) opened at 44.19 on Friday. INC Research Holdings Inc. has a 1-year low of $34.19 and a 1-year high of $57.11. The stock has a market capitalization of $2.42 billion, a price-to-earnings ratio of 21.79 and a beta of 1.80. The firm’s 50-day moving average price is $44.20 and its 200 day moving average price is $43.38.
INC Research Holdings (NASDAQ:INCR) last issued its quarterly earnings data on Thursday, July 28th. The company reported $0.61 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.58 by $0.03. The company had revenue of $258.80 million for the quarter, compared to analyst estimates of $252.39 million. INC Research Holdings had a return on equity of 46.76% and a net margin of 7.43%. The business’s quarterly revenue was up 13.8% compared to the same quarter last year. During the same quarter last year, the company posted $0.47 earnings per share. Equities research analysts expect that INC Research Holdings Inc. will post $2.47 earnings per share for the current fiscal year.
Several equities analysts have recently issued reports on INCR shares. Zacks Investment Research raised INC Research Holdings from a “hold” rating to a “strong-buy” rating and set a $51.00 price objective for the company in a report on Friday, August 19th. Credit Suisse Group AG started coverage on INC Research Holdings in a report on Monday, June 20th. They issued an “outperform” rating and a $51.00 price objective for the company. Goldman Sachs Group Inc. reissued a “conviction-buy” rating and issued a $82.00 price objective on shares of INC Research Holdings in a report on Thursday, September 8th. Finally, Jefferies Group decreased their price objective on INC Research Holdings from $56.00 to $55.00 and set a “buy” rating for the company in a report on Wednesday, August 17th. Three investment analysts have rated the stock with a hold rating, four have assigned a buy rating and two have assigned a strong buy rating to the stock. INC Research Holdings currently has a consensus rating of “Buy” and a consensus price target of $55.00.
Several institutional investors have recently modified their holdings of INCR. Rational Advisors LLC purchased a new position in shares of INC Research Holdings during the second quarter valued at about $109,000. Zurcher Kantonalbank Zurich Cantonalbank raised its position in shares of INC Research Holdings by 302.6% in the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 3,052 shares of the company’s stock valued at $116,000 after buying an additional 2,294 shares during the last quarter. Acrospire Investment Management LLC purchased a new position in shares of INC Research Holdings during the first quarter valued at about $117,000. BlackRock Inc. raised its position in shares of INC Research Holdings by 4.6% in the second quarter. BlackRock Inc. now owns 4,810 shares of the company’s stock valued at $183,000 after buying an additional 213 shares during the last quarter. Finally, Cubist Systematic Strategies LLC purchased a new position in shares of INC Research Holdings during the second quarter valued at about $190,000. 91.27% of the stock is currently owned by institutional investors.
INC Research Holdings Company Profile
INC Research Holdings, Inc is a global contract research organization (CRO). The Company is focused on Phase I to Phase IV clinical development services for the biopharmaceutical and medical device industries. The Company operates through two segments: Clinical Development Services and Phase I Services.
Receive News & Ratings for INC Research Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for INC Research Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.